Login / Signup

Survival Analysis, Clinical Characteristics, and Predictors of Cerebral Metastases in Patients with Colorectal Cancer.

Antoine Jeri-YabarLiliana Vittini-HernandezJerry K Benites-MezaSebastian Prado-Nuñez
Published in: Medical sciences (Basel, Switzerland) (2024)
BM in mCRC is uncommon, but it is associated with significantly worse outcomes, including markedly reduced overall survival. Our study highlights several critical factors associated with the presence of BM, such as older age and specific racial/ethnic groups, which may inform risk stratification and early-detection strategies. Our findings emphasize the need for heightened awareness and screening for BM in high-risk mCRC patients, as well as the inclusion of these patients in clinical trials to explore tailored therapeutic approaches aimed at improving survival and quality of life.
Keyphrases
  • clinical trial
  • ejection fraction
  • newly diagnosed
  • physical activity
  • metabolic syndrome
  • patient reported outcomes
  • skeletal muscle
  • blood brain barrier